Literature DB >> 33973176

How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment.

Amene Saghazadeh1,2, Nima Rezaei3,4,5.   

Abstract

The novel coronavirus disease (COVID-19) profoundly influences T-cell immunity. The counts of total T cells and T-cell subsets, especially CD4+ and CD8+ T cells, are decreased in patients with COVID-19. Also, the function of these cells becomes less effective as the expression of immune inhibitory receptors, such as Tim3 and PD-1, increases over time during the disease. Kinetic analyses show that the T-cell profile changes dynamically, so does the COVID-19 stages. As COVID-19 continues to deteriorate and progresses to severe/critical condition, the lymphocyte count steadily decreases. Therefore, the ability of COVID-19 to escape the immune system might lie in its power to profoundly diminish T-cell effective function, which is necessary for the establishment of a robust antiviral immunity. Also, COVID-19 is associated with increased numbers of monocytes and macrophages, and as the disease progresses from a mild form to a severe/critical condition, the macrophage population becomes denser. Monitoring the expression of cytokines associated with macrophage activation, mainly interleukin (IL)-6 and IL-10, indicates that the course of COVID-19 consists of two stages and the transition between disease stages occurs by the end of the first week after onset of symptoms. At the initial stage, the immune military recognizes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as nonself and thus fires macrophages at the lungs against the virus. The first flame can control disease progression effectively. However, a trained immunocompetent system would maintain the fire of macrophages over an extended time. It lies in its immune memory in tissue-resident macrophages, especially alveolar macrophages, making a professionally trained immune system more likely to be feared by COVID-19 than an untrained immune system. In this manner, the trained immunocompetent system commits such a failure that causes the lungs to come down rapidly. The fact that younger age groups, including neonates and children, are less susceptible to COVID-19 than older age groups reflects that the natural affinities of the immune system that has not been trained thoroughly would be standard in combatting against COVID-19 whereas the higher affinities of the trained immune system for rapid activation of immune responses might raise faults - the lungs come down.

Entities:  

Keywords:  COVID-19; Cytokine storm; Interleukin-6; Lung; Macrophage; Monocyte

Mesh:

Substances:

Year:  2021        PMID: 33973176     DOI: 10.1007/978-3-030-63761-3_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  All together to Fight COVID-19.

Authors:  Sara Momtazmanesh; Hans D Ochs; Lucina Q Uddin; Matjaz Perc; John M Routes; Duarte Nuno Vieira; Waleed Al-Herz; Safa Baris; Carolina Prando; Laszlo Rosivall; Amir Hamzah Abdul Latiff; Timo Ulrichs; Vasili Roudenok; Juan Carlos Aldave Becerra; Deepak B Salunke; Ekaterini Goudouris; Antonio Condino-Neto; Anzhela Stashchak; Oleksandr Kryvenko; Mykola Stashchak; Anastasia Bondarenko; Nima Rezaei
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

Authors:  R H Amin; R N Frank; A Kennedy; D Eliott; J E Puklin; G W Abrams
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

Review 3.  The urgent need for integrated science to fight COVID-19 pandemic and beyond.

Authors:  Negar Moradian; Hans D Ochs; Constantine Sedikies; Michael R Hamblin; Carlos A Camargo; J Alfredo Martinez; Jacob D Biamonte; Mohammad Abdollahi; Pedro J Torres; Juan J Nieto; Shuji Ogino; John F Seymour; Ajith Abraham; Valentina Cauda; Sudhir Gupta; Seeram Ramakrishna; Frank W Sellke; Armin Sorooshian; A Wallace Hayes; Maria Martinez-Urbistondo; Manoj Gupta; Leila Azadbakht; Ahmad Esmaillzadeh; Roya Kelishadi; Alireza Esteghamati; Zahra Emam-Djomeh; Reza Majdzadeh; Partha Palit; Hamid Badali; Idupulapati Rao; Ali Akbar Saboury; L Jagan Mohan Rao; Hamid Ahmadieh; Ali Montazeri; Gian Paolo Fadini; Daniel Pauly; Sabu Thomas; Ali A Moosavi-Movahed; Asghar Aghamohammadi; Mehrdad Behmanesh; Vafa Rahimi-Movaghar; Saeid Ghavami; Roxana Mehran; Lucina Q Uddin; Matthias Von Herrath; Bahram Mobasher; Nima Rezaei
Journal:  J Transl Med       Date:  2020-05-19       Impact factor: 5.531

Review 4.  Lymphopenia in COVID-19: Therapeutic opportunities.

Authors:  Nazanin Fathi; Nima Rezaei
Journal:  Cell Biol Int       Date:  2020-06-03       Impact factor: 3.612

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

Authors:  Bobak Moazzami; Niloofar Razavi-Khorasani; Arash Dooghaie Moghadam; Ermia Farokhi; Nima Rezaei
Journal:  J Clin Virol       Date:  2020-04-04       Impact factor: 3.168

7.  The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.

Authors:  Amir Hossein Mansourabadi; Mona Sadeghalvad; Hamid-Reza Mohammadi-Motlagh; Nima Rezaei
Journal:  Life Sci       Date:  2020-08-01       Impact factor: 5.037

8.  Genetic predisposition models to COVID-19 infection.

Authors:  Farzaneh Darbeheshti; Nima Rezaei
Journal:  Med Hypotheses       Date:  2020-05-06       Impact factor: 1.538

9.  Offline: COVID-19 and the NHS-"a national scandal".

Authors:  Richard Horton
Journal:  Lancet       Date:  2020-03-28       Impact factor: 79.321

Review 10.  Monoclonal antibody as a potential anti-COVID-19.

Authors:  Leila Jahanshahlu; Nima Rezaei
Journal:  Biomed Pharmacother       Date:  2020-06-04       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.